ArticleWorld journal of diabetes2026

Formononetin inhibits p53 signaling pathway activation to delay cellular senescence and ameliorates diabetic kidney disease.

Yue Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.